BSAC

Founded in 1971, the British Society for Antimicrobial Chemotherapy (BSAC) is committed to addressing the growing threat of drug resistant infections – one of the leading global causes of death.

As one of the world’s largest networks of infection specialists, BSAC works with a wide range of stakeholders, including researchers, scientists, health care providers, policymakers, and industry leaders to support their work and help them reach a global audience.

BSAC’s renowned publications are among the foremost international journals in antimicrobial research, whilst its commitment to scientific excellence is reflected in a varied programme of events, training, accreditation and free educational resources.